These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25818784)

  • 1. [Investigation of B-cell activating factor in serum and cerebrospinal fluid of patients with neuromyelitis optical].
    Yang F; Huang D; Wu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):380-3. PubMed ID: 25818784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population.
    Vaknin-Dembinsky A; Brill L; Orpaz N; Abramsky O; Karussis D
    Mult Scler; 2010 Dec; 16(12):1453-7. PubMed ID: 20935029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.
    Wang H; Wang K; Zhong X; Qiu W; Dai Y; Wu A; Hu X
    J Clin Immunol; 2012 Oct; 32(5):1007-11. PubMed ID: 22644841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission.
    Wang S; Yang T; Wan J; Zhang Y; Fan Y
    Brain Behav; 2017 Apr; 7(4):e00648. PubMed ID: 28413701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
    Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
    Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
    Quan C; Yu H; Qiao J; Xiao B; Zhao G; Wu Z; Li Z; Lu C
    Mult Scler; 2013 Mar; 19(3):289-98. PubMed ID: 22864301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.
    Wu A; Zhong X; Wang H; Xu W; Cheng C; Dai Y; Bao J; Qiu W; Lu Z; Hu X
    Can J Neurol Sci; 2012 Nov; 39(6):813-20. PubMed ID: 23041403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
    Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X
    Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability.
    Tomizawa Y; Yokoyama K; Saiki S; Takahashi T; Matsuoka J; Hattori N
    J Int Med Res; 2012; 40(4):1483-91. PubMed ID: 22971500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset.
    Puthenparampil M; Miante S; Federle L; Zanetta C; Toffanin E; Ruggero S; Rinaldi F; Gallo P
    J Neuroimmunol; 2016 Aug; 297():63-7. PubMed ID: 27397077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
    Piazza F; DiFrancesco JC; Fusco ML; Corti D; Pirovano L; Frigeni B; Mattavelli L; Andreoni S; Frigo M; Ferrarese C; Tredici G; Cavaletti G
    J Neuroimmunol; 2010 Mar; 220(1-2):104-7. PubMed ID: 20149932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica and multiple sclerosis.
    Zhang H
    Mult Scler; 2011 May; 17(5):639-40; author reply 641. PubMed ID: 21382861
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
    Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica.
    Tortorella C; Ruggieri M; Di Monte E; Ceci E; Iaffaldano P; Direnzo V; Mastrapasqua M; Frigeri A; Amato MP; Hakiki B; Ghezzi A; Lugaresi A; De Luca G; Patti F; D'Amico E; Sola P; Simone AM; Svelto M; Livrea P; Trojano M
    J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1355-9. PubMed ID: 21622936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels.
    Nakashima I; Takahashi T; Cree BA; Kim HJ; Suzuki C; Genain CP; Vincent T; Fujihara K; Itoyama Y; Bar-Or A
    J Clin Neurosci; 2011 Jul; 18(7):997-8. PubMed ID: 21565508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
    Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K
    Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
    Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
    Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.
    Cha E; Lee KM; Park KD; Park KS; Lee KW; Kim SM; Lee J
    PLoS One; 2016; 11(12):e0167819. PubMed ID: 27942009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
    Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
    Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases.
    Braun T; Juenemann M; Dornes K; El-Shazly J; Schramm P; Bick-Ackerschott S; Kaps M; Gerriets T; Blaes F; Tschernatsch M
    Int J Neurosci; 2021 Dec; 131(12):1231-1236. PubMed ID: 32602764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.